Fatty Acids, Unsaturated
In clinical developmentRecent clinical, regulatory, research and industry developments relating to this drug.
Ferroptosis in neurological diseases: moving towards therapeutic intervention.
IL-10 constrains sphingolipid metabolism to limit inflammation.
Natural Compounds and Products from an Anti-Aging Perspective.
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences3
- Marine drugs1
- Molecular psychiatry1
- Molecules (Basel, Switzerland)1
- Nature1
- Nature communications1
- Arita M1
- Barros PL1
- Bensinger SJ1
- Bjørklund G1
- Brewer JR1
- Bush AI1
- Butnariu M1
- Bydlowski SP1
- School of Medicine2
- Banat's University of Agricultural Sciences and Veterinary Medicine "King Michael I of Romania" from Timisoara1
- Centre of Research Excellence in Nutrition and Metabolism1
- Danylo Halytsky Lviv National Medical University1
- David Geffen School of Medicine1
- Department of Biochemistry and Centre of Excellence for Molecular Food Sciences1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Fatty Acids, Unsaturated in the shared literature.
Studied across 5 of the same disease areas as Fatty Acids, Unsaturated in the shared literature.
Studied across 3 of the same disease areas as Fatty Acids, Unsaturated in the shared literature.
Studied across 3 of the same disease areas as Fatty Acids, Unsaturated in the shared literature.
Studied across 3 of the same disease areas as Fatty Acids, Unsaturated in the shared literature.
Studied across 2 of the same disease areas as Fatty Acids, Unsaturated in the shared literature.
Studied across 2 of the same disease areas as Fatty Acids, Unsaturated in the shared literature.
Frequently co-studied with Fatty Acids, Unsaturated in the research literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials